1954
DOI: 10.1038/jid.1954.43
|View full text |Cite
|
Sign up to set email alerts
|

On the Development of Epidermal Methylcholanthrene Tumors in Mice Receiving Cortisone123

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

1955
1955
2012
2012

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 17 publications
(2 citation statements)
references
References 18 publications
0
2
0
Order By: Relevance
“…However, our observations do support those of and of Boutwell and Rusch (1953). Nevertheless, it should be carefully noted, since it merits such special attention, that all the investigators who reported that cortisone suppresses experimentally-induced skin neoplasia, conducted their experiments for only relatively short periods, ranging from 21 days (Baker and Whitaker, 1949) to a maximum of 26 weeks (Piccagli et al, 1954), as opposed to the experiments reported on by Boutwell and Rusch, and by ourselves, which extended over very much longer periods (up to 33 and 38 weeks in our own experiments).…”
Section: Discussionmentioning
confidence: 99%
“…However, our observations do support those of and of Boutwell and Rusch (1953). Nevertheless, it should be carefully noted, since it merits such special attention, that all the investigators who reported that cortisone suppresses experimentally-induced skin neoplasia, conducted their experiments for only relatively short periods, ranging from 21 days (Baker and Whitaker, 1949) to a maximum of 26 weeks (Piccagli et al, 1954), as opposed to the experiments reported on by Boutwell and Rusch, and by ourselves, which extended over very much longer periods (up to 33 and 38 weeks in our own experiments).…”
Section: Discussionmentioning
confidence: 99%
“…Since in previous investigations includ ing our own [2,3,4, 5] the tum or incidence was low in response to DMBA application during the growing phase of the hair cycle (anagen) and augm ented in response to application during the resting phase (telogen), we had expected a decrease in the tum or incidence under the influence of Liothyronine. This, however, did not at all hold true.…”
mentioning
confidence: 99%